VeraBank’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.27M | Sell |
10,599
-1,042
| -9% | -$120K | 0.23% | 68 |
|
|
2025
Q4 | $1.23M | Buy |
11,641
+282
| +2% | +$26.5K | 0.22% | 72 |
|
|
2025
Q3 | $953K | Buy |
11,359
+211
| +2% | +$17.4K | 0.18% | 82 |
|
|
2025
Q2 | $882K | Sell |
11,148
-830
| -7% | -$66K | 0.18% | 90 |
|
|
2025
Q1 | $1.08M | Buy |
11,978
+139
| +1% | +$13K | 0.3% | 63 |
|
|
2024
Q4 | $1.18M | Sell |
11,839
-146
| -1% | -$15.1K | 0.33% | 57 |
|
|
2024
Q3 | $1.36M | Sell |
11,985
-24
| -0.2% | -$2.85K | 0.4% | 53 |
|
|
2024
Q2 | $1.49M | Sell |
12,009
-100
| -0.8% | -$12.9K | 0.46% | 47 |
|
|
2024
Q1 | $1.6M | Sell |
12,109
-12
| -0.1% | -$1.48K | 0.5% | 47 |
|
|
2023
Q4 | $1.32M | Buy |
12,121
+252
| +2% | +$26.2K | 0.44% | 51 |
|
|
2023
Q3 | $1.22M | Hold |
11,869
| – | – | 0.47% | 51 |
|
|
2023
Q2 | $1.37M | Sell |
11,869
-133
| -1% | -$15.1K | 0.53% | 46 |
|
|
2023
Q1 | $1.28M | Sell |
12,002
-777
| -6% | -$83.9K | 0.59% | 43 |
|
|
2022
Q4 | $1.42M | Sell |
12,779
-2
| -0% | -$204 | 0.71% | 35 |
|
|
2022
Q3 | $1.1M | Hold |
12,781
| – | – | 0.69% | 37 |
|
|
2022
Q2 | $1.17M | Buy |
12,781
+363
| +3% | +$32.2K | 0.68% | 40 |
|
|
2022
Q1 | $1.02M | Sell |
12,418
-341
| -3% | -$26.9K | 0.53% | 48 |
|
|
2021
Q4 | $978K | Buy |
12,759
+189
| +2% | +$15.1K | 0.49% | 49 |
|
|
2021
Q3 | $944K | Buy |
12,570
+575
| +5% | +$43.7K | 0.53% | 44 |
|
|
2021
Q2 | $932K | Buy |
11,995
+112
| +0.9% | +$8.33K | 0.55% | 43 |
|
|
2021
Q1 | $874K | Buy |
11,883
+524
| +5% | +$38.7K | 0.57% | 42 |
|
|
2020
Q4 | $887K | Hold |
11,359
| – | – | 0.62% | 41 |
|
|
2020
Q3 | $899K | Buy |
11,359
+242
| +2% | +$19K | 0.69% | 41 |
|
|
2020
Q2 | $820K | Hold |
11,117
| – | – | 0.67% | 40 |
|
|
2020
Q1 | $816K | Hold |
11,117
| – | – | 0.79% | 38 |
|
|
2019
Q4 | $965K | Sell |
11,117
-105
| -0.9% | -$8.62K | 0.78% | 38 |
|
|
2019
Q3 | $901K | Hold |
11,222
| – | – | 0.81% | 37 |
|
|
2019
Q2 | $898K | Sell |
11,222
-397
| -3% | -$30.4K | 0.84% | 38 |
|
|
2019
Q1 | $922K | Hold |
11,619
| – | – | 0.88% | 36 |
|
|
2018
Q4 | $847K | Buy |
+11,619
| New | +$820K | 0.91% | 36 |
|
Other funds holding MRK
VCM
VPM
VeraBank's MRK Position: Q1 2026 in Review
VeraBank reduced its Merck (MRK) stake by 9% in Q1 2026, selling an estimated $120K and leaving 10,599 shares worth $1.27M. The position accounts for 0.23% of the portfolio, ranked #68.
VeraBank first reported a position in MRK in Q4 2018 and has held it in 30 quarters since. The position peaked at $1.6M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- VeraBank held 10,599 shares of Merck worth $1.27M as of Q1 2026.
- VeraBank sold 1,042 Merck shares in Q1 2026, an estimated $120K.
- Merck made up 0.23% of VeraBank's portfolio in Q1 2026, its #68 holding.
- VeraBank first reported a position in Merck in Q4 2018 and has held it in 30 quarters since.
- VeraBank's Merck position peaked at $1.6M in Q1 2024.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on VeraBank's 13F filing for Q1 2026, filed 12 May 2026.